Overview
Ramasubramanian (“Ram”) Kalpatthi, MD, is Clinical Research Director of Pediatric Sickle Cell Research and Director of PHO Medical Student and Resident Education at UPMC Children's Hospital of Pittsburgh. He is also a Visiting Associate Professor of Pediatrics at the University of Pittsburgh School of Medicine. He is board certified in pediatric hematology-oncology.He earned his medical degree from Thanjavur Medical College in Thanjavur, India. He completed a Residency at All India Institute of Medical Sciences and Lincoln Medical Center followed by a fellowship at Nationwide Children's Hospital.Dr. Kalpatthi is nationally recognized for his excellence in the clinical care, clinical research, program development and leadership in the field of pediatric hematology oncology with special emphasis on sickle cell disease (SCD) and immune thrombocytopenia (ITP). His other clinical interests include therapeutic apheresis, immune hematological disorders, neonatal hematology, benign hematological disorders, and childhood leukemia.Also, he is a favorite among medical students, residents, and fellows due to his passion for teaching, guiding, and mentoring future generation of physicians. He has mentored medical students, residents, and fellows in completing clinical research projects that have been published and/or presented at national conferences such as the American Society of Hematology (ASH), the American Society of Pediatric Hematology/Oncology (ASPHO) and Pediatric Academic Societies (PAS) meeting. Several of his mentees received outstanding abstract achievement awards for their work and most of his mentees have published their research in leading medical journals.View the full list of Dr. Kalpatthi’s publications on PubMed.
His clinical expertise encompasses Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, Hemolytic Anemia, and Splenectomy.
Dr. Kalpatthi is board certified in American Board Of Pediatrics. He is actively involved in clinical research, co-authoring 8 peer reviewed articles and participating in 2 clinical trials. Dr. Kalpatthi is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- HMO
- MANAGED MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
Locations
4401 Penn Avenue, Pittsburgh, PA 15224
Additional Areas of Focus
Dr. Kalpatthi has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Pediatric Hematology Oncology In Lawrenceville
Cheryl A. Hillery, MD, is clinical director of Hematology at UPMC Children’s Hospital of Pittsburgh and a professor of Pediatrics within the Division of Hematology-Oncology at the University of Pittsburgh School of Medicine. She is the director of the Pediatric Comprehensive Sickle Cell Program and has led basic, translational, and clinical research studies focused on sickle cell disease. Dr. Hillery is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Sickle Cell Disease, Congenital Hemolytic Anemia, Hemoglobinopathy, and Hemolytic Anemia. Dr. Hillery is board certified in American Board Of Pediatrics and American Board Of Internal Medicine . Dr. Hillery is currently accepting new patients.
Pediatric Hematology Oncology In Lawrenceville
Jessica Daley, MD, specializes in pediatric hematology and oncology and is certified in pediatrics by the American Board of Pediatrics. She practices at Pediatric Hematology Oncology in Lawrenceville and is affiliated with UPMC Magee-Womens Hospital. She completed her residency at Hasbro Children's Hospital, fellowship at University of Pittsburgh School of Medicine and medical degree at Tufts University School of Medicine. Dr. Daley is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Ewing Sarcoma, Osteosarcoma, and Adult Soft Tissue Sarcoma. Dr. Daley is board certified in American Board Of Pediatrics and American Board Of Pediatrics . Dr. Daley is currently accepting new patients.
Pediatric Hematology Oncology In Lawrenceville
Frederico Xavier, MD, MS, is the associate clinical director for the Hemophilia Center of Western Pennsylvania and an associate professor of Pediatrics at the University of Pittsburgh School of Medicine. He is board-certified in Pediatrics and in Pediatric Hematology/Oncology.Dr. Xavier completed his medical degree, pediatric residency, and fellowship training in Brazil. He then completed a pediatric residency in New York, pediatric hematology and oncology fellowship at St. Jude Children’s Hospital, and then a pediatric hemostasis fellowship at the Hospital for Sick Children in Toronto, Ontario, Canada. Dr. Xavier completed a master’s degree in clinical research at the Indiana University-Purdue University Indianapolis.He has published peer-reviewed articles and book chapters in the field of pediatric hemostasis and is currently awarded with a research grant to study inflammation in Hemophilia. Dr. Xavier also sits in the Newborn Screening and Follow-up Technical Advisory Board for the Pennsylvania Department of Health.Dr. Xavier also practices at the Hemophilia Center of Western Pennsylvania, a state and federally-funded 501(c)3 charitable organization that provides comprehensive medical care to the residents of Western Pennsylvania with hemophilia and other bleeding and clotting disorders. The functions of the center include diagnosis and evaluation of individuals with bleeding disorders; treatment of bleeding episodes and complications; education of the patient and family, the community, and other medical providers; communication and advocacy; supervision of home care; and research and data collection.View the full list of Dr. Xavier’s publications on PubMed. Dr. Xavier is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Hemophilia A, Hemophilic Arthropathy, Hemophilia B, and Von Willebrand Disease (VWD). Dr. Xavier is board certified in American Board Of Pediatrics and American Board Of Pediatrics . Dr. Xavier is currently accepting new patients.
Frequently Asked Questions about Dr. Ramasubramanian V. Kalpatthi
How do I make an appointment with Dr. Ramasubramanian V. Kalpatthi?
You can book an appointment with Dr. Ramasubramanian V. Kalpatthi by calling their office at 412-692-5055. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Ramasubramanian V. Kalpatthi a top-rated expert for Sickle Cell Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Ramasubramanian V. Kalpatthi is classified as an Experienced expert for Sickle Cell Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Ramasubramanian V. Kalpatthi specialize in?
While Dr. Ramasubramanian V. Kalpatthi is a Pediatric Hematology Oncology, they have specific expertise in Sickle Cell Disease, Hemoglobinopathy, and Congenital Hemolytic Anemia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatric Hematology Oncology.
Does Dr. Ramasubramanian V. Kalpatthi participate in research or clinical trials?
Yes. Dr. Ramasubramanian V. Kalpatthi has published 8 articles and abstracts on conditions like Sickle Cell Disease. You can view a list of Dr. Ramasubramanian V. Kalpatthi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Ramasubramanian V. Kalpatthi accept my insurance?
Dr. Ramasubramanian V. Kalpatthi accepts most major insurance plans, including Aetna and Cigna. We recommend calling the office directly at 412-692-5055 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Kalpatthi isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- AnemiaDr. Kalpatthi isExperienced. Learn about Anemia.
- Congenital Hemolytic AnemiaDr. Kalpatthi isExperienced. Learn about Congenital Hemolytic Anemia.
- HemoglobinopathyDr. Kalpatthi isExperienced. Learn about Hemoglobinopathy.
- Hemolytic AnemiaDr. Kalpatthi isExperienced. Learn about Hemolytic Anemia.
- Hepatic Venoocclusive Disease with Immunodeficiency
- Sickle Cell DiseaseDr. Kalpatthi isExperienced. Learn about Sickle Cell Disease.
- SplenectomyDr. Kalpatthi isExperienced. Learn about Splenectomy.